This pilot study was designed to establish the effect of long term alpha interferon treatment in haemophilia patients with chronic hepatitis C. Overall, three of eight (37.5%) patients showed a complete response, three of eight (37.5%) a transient response, and two of eight (25O0%) no response. HCV-RNA detection by polymerase chain reaction was more sensitive in detecting relapse than alanine aminotransferase (ALT) activity measurement, suggesting that current interferon schedules based on the ALT response should be re-evaluated criticaily.
Patients and methods
Patients were included in the trial if they had haemophilia A or B and chronic hepatitis C, with serum alanine aminotransferase (ALT) activities greater than 2 5 times the upper limit of normal on at least two occasions within six months and serum HCV-RNA detectable by cDNA polymerase chain reaction (PCR) however, (patient 3) showed a complete ALT normalisation at week 24. Even in complete responders, ALT fluctuation above the upper limit of normal, not accompanied by renewed HCV-RNA detection, was seen and is difficult to explain.
Conclusions
From the results ofthis study, we conclude that HCV-RNA detection by cDNA-PCR is a better criterion for relapse than serum ALT measurement. Current interferon alpha treatment schedules for patients with chronic hepatitis C are based on the ALT response and should be critically re-evaluated for their ability to clear HCV-RNA. 
